A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed) recently published in the Journal of Biotechnology and Biomedicine . Unlike the Pfizer and Moderna COVID-19 vaccines that use messenger RNA (mRNA) to cue the immune system to produce antibodies, this vaccine platform uses sections of viral DNA to achieve a similar result. "There is always a need to develop new, or improve on existing vaccines to ensure we have effective tools to counter emerging variants," says Texas Biomed Innovation Lab Principal Investigator Viraj Kulkarni, PhD.

https://www.miragenews.com/texas-biomed-scancell-collaborate-on-new-covid-1073945/

#miragenews